stability in aqueous solutions.
The structure of the inclusion compounds of lankacidin A is proposed based on the facility of their inclusion with ;1-cyclodextrin and the results of 1H NMR spectral studies.
Lankacidin-group antibiotics'-3' isolated from the culture filtrate of Streptomyces rochei var. volubilis4) are 17-membered macrocyclic compounds.1,5,6) They show strong protective effects in mice against Gram-positive bacteria including clinical isolates when orally or parenterally administered7) and have low toxicities in mice and rats.8) Studies on their structure-activity relationships, enzymatic reactions and metabolic fates have been reviewed.9) Recently, one of these antibiotics, lankacidin A (2) was found to be active against Treponema hyodysenteriae in vitro and was strongly effective to experimental infections in mice and pigs. 10, 11) These antibiotics are scarcely soluble in water and the parts that dissolve are rapidly decomposed to compounds having no antimicrobial activity. To overcome this problem, we considered the use of cyclodextrins (CyDs) to improve water-solubility and stability in aqueous solutions by forming inclusion compounds with various kinds of organic compounds.12) We prepared inclusion compounds of the antibiotics and examined their characteristics for use by injection. This report deals with the inclusion compounds of lankacidin-group antibiotics formed with CyDs.
Materials and Methods

Antibiotics and Reagents
Lankacidin-group and other antibiotics were prepared in our laboratories; This numbering system is based on the IUPAC nomenclature rules, and differs from that in Table 1 . CyDs were purchased from Wako Pure Chemicals (Osaka, Japan).
Estimation of Solubility
An excess amount of an antibiotic was added to a solution containing CyDs and the suspension was stirred at 7°C for 30 minutes to 2 hours.
The insoluble part was removed with a filter paper (Toyoroshi, No. 5c) or a millipore filter (Millipore Corp, USA, 0.45 Fpm), and the amount of antibiotic in the filtrate was estimated by the UV absorbance at 226 to 228 nm.
Preparation of Inclusion Compounds
Method I: A small excess of the antibiotic calculated from the saturated solubility of the antibiotic 
High-performance Liquid Chromatography (HPLC)
A Model 6000 A/660/440 instrument was used with a column of reverse-phase tBondapak C18 (Waters Assoc.). The flow rate of the mobile phase was 1 ml/minute with CH,CN -0.01 M phosphate buffer, pH 7.7, (4: 6). The retention time of 1 was 5.6 minutes under these conditions.
Results and Discussion
The solubilities for CyD solutions were first examined using lankacidin C (1) which is antimicrobially the most active among lankacidin-group antibiotics (Table 2 ). 1 showed remarkable solubility increase for 0.01 M ~-CyD solution but no increase for a-CyD solutions. The solubility was increased by 1-CyD solutions but 10 times more 7-CyD than '3-CyD was needed to obtain the same level of solubility. Lankacidin C 8-propionate (5) and 14-propionate (3) were subjected to the solubility test to find the effect of the substitution position on the inclusion ability of CyDs (Table 2) . 5 showed a greater increase of solubility with 3-CyD solution than 7-CyD solution. These data suggested that ,3-CyD is the best inclusion host for lankacidin-group antibiotics. However, the positional isomer, 3, showed smaller increase of solubilities for CyD solutions than 5.
Solubility changes of 2, 1 and lankacidinol (10), which displayed typically distinctive solubilities for water and the Rf values on TLC (Table 1) , were found for the 33-CyD solution. Three antibiotics increased their solubilities for 3-CyD solutions as the 3-CyD concentration increased (Table 3 ). The stability constants in 0.01 M 8-CyD solutions were calculated to be 2,800 for 2, 4,270 for 1 and 1,480 Table   2 . Solubilities of 1, 5 and 3 for S-CyD solutions (mg/ml). a The maximum solu bility of 3-CyD for H_O was 11.3 mg/ml at 7°C. When the 13-CyD inclusion compounds of these antibiotics prepared by Method I were dissolved in water, their solubilities (Table 4) were about 330 times higher for 2 and about 340 times for 1 than the solubilities of the antibiotics for water ( Table 1) . Powders of 1 and 10 recovered by freeze-drying the solutions showed almost the same level of antibiotic content as compared with the initial samples.
In the case of 2, the contents in the recovered powder increased slightly to reach the same level as 1 and 10. This suggests that free /3-CyD used in the preparation of the inclusion compound of 2 was excluded by re-dissolution and therefore, the molar ratios between the antibiotics and 1S-CyD are consistent among the inclusion compounds. The freeze-dried powders prepared by Method II showed similar antibiotic contents and solubilities for water to those prepared by Method I.
The freeze-dried inclusion compound of 1 was remarkably stable in the j-CyD solution at 25°C
in comparison with 1 in water as shown in Table 5 . These findings indicate that the powder prepared by the freeze-drying method may keep some stable form(s) of i4-CyD inclusion compounds, which im- hydrolankacidin C (9) and 4) the 18-carbonyl group is also essential according to the data for lankacidinol A (11) and its 18-ol compound (14).
The absolute configuration of 2 has been determined by X-ray crystallographic analysis of its 2' p-bromophenyl hydrazone.14) According to the data, the space atomic distances from C-8 to C-17
and from C-3 to C-15 are 6.32 A and 6.43 A, respectively, which are almost the same as the internal cavity size of rS-CyD, 6.0" 6.4 A.12) Therefore, the skeleton of the antibiotic can not enter the /3-CyD cavity. 1H NMR spectral studies were carried out to elucidate the structure of the 3-CyD inclusion compound of 2. When the added spectrum of 2 (60 l<g/0.3 ml at 5°C) and /3-CyD alone (5 mg/0.3 ml) in deuterium oxide was compared to the spectrum of the 13-CyD inclusion compound of 2 (5 mg/0.3 ml as the antibiotic) (Table 6 ), the proton signal at position 3 showed an upfield shift (-0.088) from Most of these protons are located at the 18-carbonyl site in the absolute structure of 2. Thus, the included position of the antibiotic is the 18-carbonyl site.
The binding between the antibiotics and R-CyD is assumed to be a loose one, like hydrogen bonding or van der Waals forces, because the antibiotics can be easily recovered by ethyl acetate extraction from an aqueous solution of the (3-CyD inclusion compounds and the enzymatic reactions at position 14 proceed in (3-CyD solution without any resistance. c Suspension with 5 % gum arabic.
The structure of the 3-CyD inclusion compound of 2 was deduced to be that shown in Fig. 2 .
The figure is depicted by 3-dimensional computer graphic techniques with van der Waals radii.
The solubilities of leucomycin A315) (=josamycin), a 16-membered macrolide, and folimycin16) (=concanamycin A),17) an 18-membered macrocyclic lactone compound, were tested by the same method. They did not show the improved solubilities for the 3-CyD solution, although they have similar structures and Rf values on TLC (Table 1 ). These findings suggested that this type of inclusion occurs specifically in compounds having the skeleton of the lankacidin-group antibiotics. Table 7 shows the protective effects of the S-CyD inclusion compounds of 2, 1, 11 and 10, which are important antimicrobially active metabolites,18) on experimental Treponeina hyodysenteriae infection in mice. 2 and 1 had effects similar to those of 2 given by suspension, but 11 and 10 were inferior to 2 and 1. The ,3-CyD inclusion compound of 2 was effective against swine dysentery in the field at similar doses to those in mice by intramuscular administration. Trials for application is now in progress.
